Sort
15,273 grants matching “antimicrobial resistance”
Project 2: Essential metabolic objectives of M. tuberculosis aerobiology
$792,016Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
$791,431Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2023 · AI
Structure, function, and regulation of the bacterial transcription cycle
$790,955Seth A Darst · Rockefeller University · R35 · FY2016 · GM
Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selection
$790,839Kieran O'Brien · University Of California, San Francisco · R01 · FY2024 · AI
Pain drugs based on nicotinic receptor subtype antagonists
$790,424Kelvin W Gee · University Of California-Irvine · R01 · FY2017 · DA
Task C06: Preparation of a non-GMP Antibiotic Candidate
$789,646Greg Martin · Albany Molecular Research, Inc. · N01 · FY2019 · AI
Personalized Antimicrobial Combinations to Combat Resistance
$789,527Vincent H Tam · University Of Houston · R01 · FY2025 · AI
Defining functional humoral correlates of immunity to guide vaccine design
$788,464Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2024 · AI
Defining functional humoral correlates of immunity to guide vaccine design
$788,432Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2025 · AI
Resistance Suppression for P. Aeruginosa using Novel Combination Therapy Modeling
$787,916George Louis Drusano · Ordway Research Institute, Inc. · R01 · FY2008 · AI
Foam cells as drug targets in tuberculosis
$787,897Maria Laura Gennaro · Rbhs-New Jersey Medical School · R01 · FY2021 · HL
Trial of Metformin for TB/HIV Host-directed Therapy
$787,888Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · U01 · FY2020 · AI
Bacillus subtilis stress responses
$787,557John D. Helmann · Cornell University · R35 · FY2022 · GM
Foam cells as drug targets in tuberculosis
$787,457Maria Laura Gennaro · Rbhs-New Jersey Medical School · R01 · FY2020 · HL
Bacillus subtilis stress responses
$787,258John D. Helmann · Cornell University · R35 · FY2024 · GM
Targeting Estrogenic pathways in Tregs to promote ARDS resolution
$787,156Franco Rafael D'alessio · Johns Hopkins University · R01 · FY2024 · HL
Foam cells as drug targets in tuberculosis
$787,112Maria Laura Gennaro · Rbhs-New Jersey Medical School · R01 · FY2022 · HL
Population Genomic Analysis of Gut Microbial Colonization in Premature Infants
$786,685Jillian Banfield · University Of California Berkeley · R01 · FY2021 · AI
Preclinical modeling to study Tuberculous Meningitis
$786,130Sanjay Jain · Johns Hopkins University · R01 · FY2023 · AI
Rapid ID and AST Directly from Whole Blood Using Single Molecule Detection
$785,846Alfredo Andres Celedon · Scanogen, Inc. · R01 · FY2024 · AI
VENOUS: A translational study of enterococcal bacteremia
$785,566Cesar Augusto Arias · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · AI
Rapid ID and AST Directly from Whole Blood Using Single Molecule Detection
$785,440Alfredo Andres Celedon · Scanogen, Inc. · R01 · FY2025 · AI
Microbial Community Disruption Following Topical Antimicrobial Application in Staphylococcus aureus-Affected Households
$785,082Stephanie Ann Fritz · Washington University · R01 · FY2021 · AI
Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses
$784,890Ann R Falsey · University Of Rochester · R01 · FY2019 · AI
Investigating nanobodies to target multidrug resistant bacterial pathogens
$784,687Bryan William Davies · University Of Texas At Austin · R01 · FY2020 · AI